• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杜氏利什曼原虫DNA拓扑异构酶IB的缺失研究:寻找最小功能异二聚体

Deletion study of DNA topoisomerase IB from Leishmania donovani: searching for a minimal functional heterodimer.

作者信息

Díaz González Rosario, Pérez Pertejo Yolanda, Ordóñez David, Balaña-Fouce Rafael, Reguera Rosa M

机构信息

Departamento de Farmacología y Toxicología (INTOXCAL), Universidad de León, León, Spain.

出版信息

PLoS One. 2007 Nov 14;2(11):e1177. doi: 10.1371/journal.pone.0001177.

DOI:10.1371/journal.pone.0001177
PMID:18000548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2063514/
Abstract

The substantial differences between trypanosomal and leishmanial DNA topoisomerase IB concerning to their homologues in mammals have provided a new lead in the study of the structural determinants that can be effectively targeted. Leishmania donovani, the causative agent of visceral leishmaniasis, contains an unusual heterodimeric DNA topoisomerase IB. The catalytically active enzyme consists of a large subunit (LdTopIL), which contains the non-conserved N-terminal end and the phylogenetically conserved "core" domain, and of a small subunit (LdTopIS) which harbors the C-terminal region with the characteristic tyrosine residue in the active site. Heterologous co-expression of LdTopIL and LdTopIS genes in a topoisomerase I deficient yeast strain, reconstitutes a fully functional enzyme LdTopIL/S which can be used for structural studies. An approach by combinatorial cloning of deleted genes encoding for truncated versions of both subunits was used in order to find out structural insights involved in enzyme activity or protein-protein interaction. The role played by the non-conserved N-terminal extension of LdTopIL in both relaxation activity and CPT sensitivity has been examined co-expressing the full-length LdTopIS and a fully active LdTopIDeltaS deletion with several deletions of LdTopIL lacking growing sequences of the N-terminal end. The sequential deletion study shows that the first 26 amino acids placed at the N-terminal end and a variable region comprised between Ala548 to end of the C-terminal extension of LdTopIL were enzymatically dispensable. Altogether this combinatorial approach provides important structural insights of the regions involved in relaxation activity and for understanding the atypical structure of this heterodimeric enzyme.

摘要

锥虫和利什曼原虫的DNA拓扑异构酶IB与其哺乳动物同源物之间的显著差异,为可有效靶向的结构决定因素的研究提供了新线索。内脏利什曼病的病原体杜氏利什曼原虫含有一种不寻常的异源二聚体DNA拓扑异构酶IB。具有催化活性的酶由一个大亚基(LdTopIL)和一个小亚基(LdTopIS)组成,大亚基包含非保守的N末端和系统发育保守的“核心”结构域,小亚基含有C末端区域,其活性位点带有特征性酪氨酸残基。LdTopIL和LdTopIS基因在拓扑异构酶I缺陷酵母菌株中的异源共表达,重构了一种可用于结构研究的全功能酶LdTopIL/S。为了找出参与酶活性或蛋白质-蛋白质相互作用的结构见解,采用了对编码两个亚基截短版本的缺失基因进行组合克隆的方法。通过共表达全长LdTopIS和具有几种LdTopIL缺失(缺少N末端不断增长的序列)的完全活性LdTopIDeltaS缺失,研究了LdTopIL非保守N末端延伸在松弛活性和CPT敏感性中所起的作用。序列缺失研究表明,位于N末端的前26个氨基酸以及LdTopIL C末端延伸的Ala548至末端之间的可变区域在酶促反应中是可有可无的。总之,这种组合方法为参与松弛活性的区域提供了重要的结构见解,并有助于理解这种异源二聚体酶的非典型结构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dff/2063514/e5aa23db7eb1/pone.0001177.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dff/2063514/5d3164591c41/pone.0001177.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dff/2063514/bae14a6426a0/pone.0001177.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dff/2063514/a7bb22f704e5/pone.0001177.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dff/2063514/93e164e351a4/pone.0001177.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dff/2063514/e5aa23db7eb1/pone.0001177.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dff/2063514/5d3164591c41/pone.0001177.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dff/2063514/bae14a6426a0/pone.0001177.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dff/2063514/a7bb22f704e5/pone.0001177.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dff/2063514/93e164e351a4/pone.0001177.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dff/2063514/e5aa23db7eb1/pone.0001177.g005.jpg

相似文献

1
Deletion study of DNA topoisomerase IB from Leishmania donovani: searching for a minimal functional heterodimer.杜氏利什曼原虫DNA拓扑异构酶IB的缺失研究:寻找最小功能异二聚体
PLoS One. 2007 Nov 14;2(11):e1177. doi: 10.1371/journal.pone.0001177.
2
Structural insights on the small subunit of DNA topoisomerase I from the unicellular parasite Leishmania donovani.来自单细胞寄生虫杜氏利什曼原虫的DNA拓扑异构酶I小亚基的结构见解。
Biochimie. 2007 Dec;89(12):1517-27. doi: 10.1016/j.biochi.2007.07.015. Epub 2007 Jul 31.
3
Mutational study of the "catalytic tetrad" of DNA topoisomerase IB from the hemoflagellate Leishmania donovani: Role of Asp-353 and Asn-221 in camptothecin resistance.来自血液鞭毛虫杜氏利什曼原虫的DNA拓扑异构酶IB“催化四联体”的突变研究:天冬氨酸-353和天冬酰胺-221在喜树碱抗性中的作用
Biochem Pharmacol. 2008 Sep 1;76(5):608-19. doi: 10.1016/j.bcp.2008.06.019. Epub 2008 Jul 4.
4
Amino acids 39-456 of the large subunit and 210-262 of the small subunit constitute the minimal functionally interacting fragments of the unusual heterodimeric topoisomerase IB of Leishmania.利什曼原虫异常异二聚体拓扑异构酶IB的大亚基39 - 456位氨基酸和小亚基210 - 262位氨基酸构成了其最小功能相互作用片段。
Biochem J. 2008 Jan 15;409(2):481-9. doi: 10.1042/BJ20071358.
5
Leishmania donovani bisubunit topoisomerase I gene fusion leads to an active enzyme with conserved type IB enzyme function.杜氏利什曼原虫双亚基拓扑异构酶I基因融合产生具有保守的IB型酶功能的活性酶。
FEBS J. 2007 Jan;274(1):150-63. doi: 10.1111/j.1742-4658.2006.05572.x.
6
Identification and characterization of the regions involved in the nuclear translocation of the heterodimeric leishmanial DNA topoisomerase IB.鉴定并阐明与双体利什曼原虫 DNA 拓扑异构酶 IB 核转位相关的区域。
PLoS One. 2013 Sep 2;8(9):e73565. doi: 10.1371/journal.pone.0073565. eCollection 2013.
7
A pentapeptide signature motif plays a pivotal role in Leishmania DNA topoisomerase IB activity and camptothecin sensitivity.一个五肽特征基序在利什曼原虫DNA拓扑异构酶IB活性和喜树碱敏感性中起关键作用。
Biochim Biophys Acta. 2012 Dec;1820(12):2062-71. doi: 10.1016/j.bbagen.2012.09.005. Epub 2012 Sep 18.
8
N-terminal region of the large subunit of Leishmania donovani bisubunit topoisomerase I is involved in DNA relaxation and interaction with the smaller subunit.杜氏利什曼原虫双亚基拓扑异构酶I大亚基的N端区域参与DNA松弛以及与小亚基的相互作用。
J Biol Chem. 2005 Apr 22;280(16):16335-44. doi: 10.1074/jbc.M412417200. Epub 2005 Feb 12.
9
The large subunit of Leishmania topoisomerase I functions as the 'molecular steer' in type IB topoisomerase.利什曼原虫拓扑异构酶I的大亚基在IB型拓扑异构酶中起“分子导向”作用。
Mol Microbiol. 2008 Jan;67(1):31-46. doi: 10.1111/j.1365-2958.2007.06002.x. Epub 2007 Nov 25.
10
Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits.通过靶向大、小亚基之间的蛋白-蛋白相互作用发现杜氏利什曼原虫拓扑异构酶 IB 选择性抑制剂。
Biochem Biophys Res Commun. 2021 Sep 10;569:193-198. doi: 10.1016/j.bbrc.2021.07.019. Epub 2021 Jul 10.

引用本文的文献

1
Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.锥虫拓扑异构酶再探讨。新的结构发现及其在药物研发中的作用。
Int J Parasitol Drugs Drug Resist. 2014 Aug 24;4(3):326-37. doi: 10.1016/j.ijpddr.2014.07.006. eCollection 2014 Dec.
2
Synthesis of marine α-methoxylated fatty acid analogs that effectively inhibit the topoisomerase IB from Leishmania donovani with a mechanism different from that of camptothecin.海洋 α-甲氧基脂肪酸类似物的合成,有效抑制拓扑异构酶 IB 从利什曼原虫与喜树碱不同的机制。
Mar Drugs. 2013 Sep 30;11(10):3661-75. doi: 10.3390/md11103661.
3
Indotecan (LMP400) and AM13-55: two novel indenoisoquinolines show potential for treating visceral leishmaniasis.

本文引用的文献

1
Amino acids 39-456 of the large subunit and 210-262 of the small subunit constitute the minimal functionally interacting fragments of the unusual heterodimeric topoisomerase IB of Leishmania.利什曼原虫异常异二聚体拓扑异构酶IB的大亚基39 - 456位氨基酸和小亚基210 - 262位氨基酸构成了其最小功能相互作用片段。
Biochem J. 2008 Jan 15;409(2):481-9. doi: 10.1042/BJ20071358.
2
Structural insights on the small subunit of DNA topoisomerase I from the unicellular parasite Leishmania donovani.来自单细胞寄生虫杜氏利什曼原虫的DNA拓扑异构酶I小亚基的结构见解。
Biochimie. 2007 Dec;89(12):1517-27. doi: 10.1016/j.biochi.2007.07.015. Epub 2007 Jul 31.
3
英地卡丹(LMP400)和 AM13-55:两种新型吲并异喹啉类化合物具有治疗内脏利什曼病的潜力。
Antimicrob Agents Chemother. 2012 Oct;56(10):5264-70. doi: 10.1128/AAC.00499-12. Epub 2012 Jul 30.
4
Gene disruption of the DNA topoisomerase IB small subunit induces a non-viable phenotype in the hemoflagellate Leishmania major.DNA拓扑异构酶IB小亚基的基因破坏在血液鞭毛虫利什曼原虫中诱导出一种不可存活的表型。
BMC Microbiol. 2008 Jul 8;8:113. doi: 10.1186/1471-2180-8-113.
Topoisomerase I inhibitors: camptothecins and beyond.
拓扑异构酶I抑制剂:喜树碱及其衍生物
Nat Rev Cancer. 2006 Oct;6(10):789-802. doi: 10.1038/nrc1977.
4
Targeting atypical trypanosomatid DNA topoisomerase I.靶向非典型锥虫DNA拓扑异构酶I。
Drug Discov Today. 2006 Aug;11(15-16):733-40. doi: 10.1016/j.drudis.2006.06.014.
5
DNA topoisomerase I from parasitic protozoa: a potential target for chemotherapy.寄生原生动物的DNA拓扑异构酶I:化疗的潜在靶点。
Biochim Biophys Acta. 2006 Mar-Apr;1759(3-4):117-31. doi: 10.1016/j.bbaexp.2006.03.006. Epub 2006 Apr 26.
6
The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA.杜氏利什曼原虫异二聚体拓扑异构酶I与带切口DNA形成的钒酸盐复合物的过渡态结构。
J Mol Biol. 2006 Apr 7;357(4):1202-10. doi: 10.1016/j.jmb.2006.01.022. Epub 2006 Jan 26.
7
Advances in leishmaniasis.利什曼病的研究进展
Lancet. 2005;366(9496):1561-77. doi: 10.1016/S0140-6736(05)67629-5.
8
Topoisomerase I amino acid substitutions, Gly185Arg and Asp325Glu, confer camptothecin resistance in Leishmania donovani.拓扑异构酶I的氨基酸取代,即甘氨酸185突变为精氨酸和天冬氨酸325突变为谷氨酸,赋予杜氏利什曼原虫对喜树碱的抗性。
Antimicrob Agents Chemother. 2005 Apr;49(4):1441-6. doi: 10.1128/AAC.49.4.1441-1446.2005.
9
RNA interference of Trypanosoma brucei topoisomerase IB: both subunits are essential.布氏锥虫拓扑异构酶IB的RNA干扰:两个亚基均必不可少。
Mol Biochem Parasitol. 2004 Aug;136(2):249-55. doi: 10.1016/j.molbiopara.2004.04.006.
10
Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints.喜树碱与拓扑异构酶I:初窥门径。用喜树碱及新型抗癌药物靶向作用于拓扑异构酶I以外的基因组:DNA复制、修复及细胞周期检查点的重要性。
Curr Med Chem Anticancer Agents. 2004 Sep;4(5):429-34. doi: 10.2174/1568011043352777.